NCT00028561 arm group 77c29366631aa4b2c944447b6ecab9f9 [clinicaltrials_resource:NCT00028561/arm-group/77c29366631aa4b2c944447b6ecab9f9]
ixabepilone [clinicaltrials_resource:979ad097feccc5161a6db957ab88a187]pharmacological study [clinicaltrials_resource:a8e73b6af9879a1838bbf23aaab2d9ad]carboplatin [clinicaltrials_resource:cf45d27bbc657f4ca1033f3ab11941cc]laboratory biomarker analysis [clinicaltrials_resource:ecba4422516392f7342d3d1a497b1ee0]BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00028561]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00028561 arm group 77c29366631aa4b2c944447b6ecab9f9 [clinicaltrials_resource:NCT00028561/arm-group/77c29366631aa4b2c944447b6ecab9f9]
Bio2RDF identifier
NCT00028561/arm-group/77c29366631aa4b2c944447b6ecab9f9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... c29366631aa4b2c944447b6ecab9f9
description [clinicaltrials_vocabulary:description]
Patients receive BMS-247550 IV ...... or up to a total of 6 courses
identifier
clinicaltrials_resource:NCT00028561/arm-group/77c29366631aa4b2c944447b6ecab9f9
title
NCT00028561 arm group 77c29366631aa4b2c944447b6ecab9f9
@en
type
label
NCT00028561 arm group 77c29366 ...... 29366631aa4b2c944447b6ecab9f9]
@en